NO DETECTABLE RESISTANCE TO BULEVIRTIDE MONOTHERAPY THROUGH 96 WEEKS TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS D

被引：0
|
作者：
Aleman, Soo [1 ]
Liu, Yang [2 ]
Xu, Simin [2 ]
Chang, Silvia [2 ]
Martin, Ross [2 ]
Aeschbacher, Thomas [2 ]
May, Lindsey [2 ]
Manhas, Savrina [2 ]
Han, Dong [2 ]
Yazdi, Tahmineh [2 ]
Martinez, Clarissa [2 ]
Ho, Pui Yan [2 ]
Richards, Christopher [2 ]
Marceau, Caleb [2 ]
Manuilov, Dmitry [2 ]
Flaherty, John F. [2 ]
Maiorova, Evguenia [2 ]
Mo, Hongmei [2 ]
Wedemeyer, Heiner [3 ]
Lampertico, Pietro [4 ]
机构：
[1] Karolinska Inst, Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
[2] Gilead Sci Inc, Foster City, CA 94404 USA
[3] Hannover Med Sch, Hannover, Germany
[4] Univ Milan, Dept Pathophysiol & Transplantat, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1237-C
引用
收藏
页码：S398 / S399
页数：2
相关论文
共 50 条
  • [41] Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
    Asselah, Tarik
    Chulanov, Vladimir
    Lampertico, Pietro
    Wedemeyer, Heiner
    Streinu-Cercel, Adrian
    Pantea, Victor
    Lazar, Stefan
    Placinta, Gheorghe
    Gherlan, George S.
    Bogomolov, Pavel
    Stepanova, Tatyana
    Morozov, Viacheslav
    Syutkin, Vladimir
    Sagalova, Olga
    Manuilov, Dmitry
    Mercier, Renee-Claude
    Ye, Lei
    Da, Ben L.
    Chee, Grace
    Lau, Audrey H.
    Osinusi, Anu
    Bourliere, Marc
    Ratziu, Vlad
    Pol, Stanislas
    Hilleret, Marie-Noelle
    Zoulim, Fabien
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02): : 133 - 143
  • [42] HBS ISOFORMS AS INNOVATIVE BIOMARKERS IN PREDICTING VIROLOGICAL RESPONSE TO BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA
    D'Anna, Stefano
    Salpini, Romina
    Degasperi, Elisabetta
    Duca, Leonardo
    Anolli, Maria Paola
    Piermatteo, Lorenzo
    Sambarino, Dana
    Borghi, Marta
    Silberstein, Francesca Ceccherini
    Facchetti, Floriana
    Perbellini, Riccardo
    Svicher, Valentina
    Lampertico, Pietro
    HEPATOLOGY, 2024, 80 : S668 - S669
  • [43] Bulevirtide for chronic hepatitis D: phase III data
    Hindson, Jordan
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (09) : 559 - 559
  • [44] Bulevirtide in chronic hepatitis D: a profile of its use
    Connie Kang
    Drugs & Therapy Perspectives, 2021, 37 : 294 - 299
  • [45] IMPROVEMENT IN NONINVASIVE TESTS ( LSM, FIB-4, AND APRI) IS SEEN THROUGH 96 WEEKS OF BULEVIRTIDE MONOTHERAPY IN CHD REGARDLESS OF VIROLOGIC RESPONSE
    Castera, Laurent
    Aleman, Soo
    Lampertico, Pietro
    Bogomolov, Pavel
    Manuilov, Dmitry
    An, Qi
    Da, Ben L.
    Flaherty, John F.
    Mercier, Renee-Claude
    Lau, Audrey H.
    Chee, Grace
    Stepanova, Tatyana
    Zeuzem, Stefan
    Wedemeyer, Heiner
    Bourliere, Marc
    Zoulim, Fabien
    Asselah, Tarik
    Brunetto, Maurizia R.
    HEPATOLOGY, 2023, 78 : S572 - S574
  • [46] Bulevirtide monotherapy in patients with chronic HDV needs further evaluation
    Li, Jianing
    Xing, Guoli
    Tong, Ying
    JOURNAL OF HEPATOLOGY, 2025, 82 (02) : e110 - e111
  • [47] Bulevirtide and emerging drugs for the treatment of hepatitis D
    Xu, Helen Y.
    Yang, Jamie O.
    Chen, Phillip H.
    Han, Steven-Huy B.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (12) : 1245 - 1253
  • [48] NO DETECTED RESISTANCE TO TENOFOVIR DISOPROXIL FUMARATE THROUGH 96 WEEKS OF TREATMENT IN CHILDREN AGE 2 TO <12 YEARS WITH CHRONIC HEPATITIS B
    Chang, Mei-Hwei
    Bezerra, Jorge A.
    Kim, Kyung Mo
    Choe, Byung-Ho
    Liu, Yang
    Feierbach, Becket
    Mo, Hongmei
    Flaherty, John F.
    Suri, Vithika
    Leung, Daniel H.
    HEPATOLOGY, 2019, 70 : 630A - 631A
  • [49] Efficacy and Safety of Bulevirtide Monotherapy for Chronic Hepatitis Delta in Patients With and Without Cirrhosis: Results From the Week 96 Interim Analysis of a Phase 3 Randomized Study
    Aleman, Soo
    Wedemeyer, Heiner
    Brunetto, Maurizia
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Da, Ben
    Flaherty, John F.
    Buensuceso, Paul
    Osinusi, Anu
    Lau, Audrey H.
    Christian-Cox, Florence
    Tseng, Steve
    zur Wiesch, Julian Schulze
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1384 - S1385
  • [50] Bulevirtide for the treatment of hepatitis B with hepatitis D virus coinfection
    Durmashkina, Elena
    Sarrazin, Christoph
    Nitschmann, S.
    INNERE MEDIZIN, 2024, 65 (07): : 746 - 748
12345